Michael Fenn, Ph.D.

Michael Fenn, Ph.D. is a Venture Partner at Iaso Ventures, where he plays a key role in the firm's investment activities.13 His responsibilities include sourcing deals, assisting with scientific and business due diligence, and stress testing new company concepts.15

Professional Background

Currently, Dr. Fenn serves as the Head of External Innovation at Dewpoint Therapeutics.12 He brings extensive experience in technology translation, basic and applied research, business strategy, and multi-disciplinary scientific expertise to his roles.1

Previous Positions::

• Director of Healthcare & Life Sciences at Harvard Innovation Labs1
• Assistant Professor of Biomedical Engineering at Florida Institute of Technology1

During his time at Harvard Innovation Labs, Dr. Fenn was instrumental in overseeing startup incubation and advising Harvard-affiliated founders.1 He also co-led the planning of Life Lab Longwood, a new translational biotech incubator at Harvard Medical School.1

Entrepreneurial Experience

Dr. Fenn has a strong track record in entrepreneurship and innovation:

• Successfully oversaw the spinout of two companies from his lab, including a YC-backed, ML-driven diagnostic startup (Luminist Labs) that was later acquired1
• Serves as an advisor to the UCF Business Incubator, providing keynote talks on early-stage startup development, fundraising strategy, and venture capital2

Education

Michael Fenn holds impressive academic credentials:

• Ph.D. in Biomedical Engineering
• M.S. in Materials Science & Engineering
• B.S. in Chemistry/Biochemistry1

Expertise and Passion

Dr. Fenn is particularly passionate about bridging the gap between academic research and company creation, having worked extensively at this interface of business and science.1 His diverse experience in the life sciences and healthcare space makes him a valuable asset to both Iaso Ventures and the broader entrepreneurial ecosystem.4